MAPK3 and cardiac hypertrophy: ERK1/2 has been considered as the central mediator of cardiac hypertrophy, although the therapeutic value of inhibiting ERK in pressure overload induced cardiac hypertrophy remained disputable [49], previous investigations have clearly demonstrated that cardiac ERK1/2 over-activation directly leads to heart hypertrophy [50].